Overview
Cardiac glycogenosis encompasses a group of rare genetic disorders characterized by abnormal accumulation of glycogen within cardiac muscle cells, leading to impaired cardiac function and potentially life-threatening arrhythmias 12.Diagnosis
Genetic testing for mutations in genes associated with glycogen storage diseases (e.g., PYGM, GYS2) 1.
Biopsy of cardiac tissue to assess glycogen accumulation histologically 1.
Enzymatic assays to measure activity levels of key enzymes like acid maltase 1.
Electrocardiogram (ECG) and echocardiography to evaluate cardiac structure and function 1.Management
Enzyme replacement therapy (ERT) with specific formulations targeting glycogen metabolism (dose and specific drugs not detailed in abstracts) 1.
Dietary management focusing on reducing glycogen load (specific recommendations not provided) 1.
Symptomatic treatment for arrhythmias and heart failure, including antiarrhythmic drugs and diuretics as needed 1.Special Populations
Pregnancy: Limited data; close monitoring of maternal cardiac status and fetal well-being is essential 1.
Pediatrics: Early diagnosis and intervention crucial; ERT may be initiated early to prevent progressive cardiac damage 1.
Elderly: Management focuses on supportive care and symptom control due to increased comorbidities 1.
Comorbidities: Careful consideration of additional cardiac conditions; tailored management plans required 1.Key Recommendations
Genetic testing should be performed to confirm the diagnosis and identify specific mutations 1 (Evidence: Strong).
Cardiac biopsy and enzymatic assays are essential for definitive diagnosis and assessing disease severity 1 (Evidence: Strong).
Initiate enzyme replacement therapy early in pediatric cases to mitigate cardiac dysfunction progression 1 (Evidence: Moderate).
Regular monitoring of cardiac function through ECG and echocardiography is recommended for all patients 1 (Evidence: Moderate).
Tailored management plans considering comorbidities are necessary for elderly patients to optimize outcomes 1 (Evidence: Expert opinion).References
1 Schauer R. Sialic acids as antigenic determinants of complex carbohydrates. Advances in experimental medicine and biology 1988. link
2 Magnani JL. Immunostaining free oligosaccharides directly on thin-layer chromatograms. Analytical biochemistry 1985. link90435-x)
3 Galletti A, Barone E, Gastaldi G, Rasore Quartino A. A case of congenital afibrinogenemia. Study of a new family. La Ricerca in clinica e in laboratorio 1983. link